Should we be targeting triglyceride as well as LDL cholesterol in the battle against coronary heart disease?

被引：0
|
作者：
Gaw, Allan [1 ]
机构：
[1] Univ Glasgow, Western Infirm, Glasgow Clin Res Facil, Glasgow G11 6NT, Lanark, Scotland
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2008年 / 5卷 / 08期
关键词：
acute coronary syndrome; coronary heart disease; LDL cholesterol; statin; triglyceride;
D O I：
10.1038/ncpcardio1249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：438 / 439
页数：2
相关论文
共 50 条
  • [31] The changes in achievement of target LDL-cholesterol levels between 2006 and 2017 in Czech patients with chronic coronary heart disease
    Vorlickova, Pavla
    Mayer, Otto, Jr.
    Bruthans, Jan
    Seidlerova, Jitka
    Gelzinsky, Julius
    Materankova, Marketa
    Cvicela, Martina
    Cifkova, Renata
    Filipovsky, Jan
    COR ET VASA, 2019, 61 (01) : E20 - E26
  • [32] Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study)
    Garmendia, F
    Brown, AS
    Reiber, I
    Adams, PC
    CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (03) : 208 - 219
  • [33] Comparison of remnant cholesterol levels estimated by calculated and measured LDL-C levels in Chinese patients with coronary heart disease
    Xiang, Qun-yan
    Tian, Feng
    Lin, Qiu-zhen
    Du, Xiao
    Zhang, Shi-lan
    Gui, Ya-jun
    Guo, Li-ling
    Xu, Jin
    Zhu, Li-yuan
    Wen, Tie
    Liu, Ling
    CLINICA CHIMICA ACTA, 2020, 500 : 75 - 80
  • [34] An 8-SNP LDL Cholesterol Polygenic Score: Associations with Cardiovascular Risk Traits, Familial Hypercholesterolemia Phenotype, and Premature Coronary Heart Disease in Central Romania
    Manescu, Ion Bogdan
    Gabor, Manuela Rozalia
    Moldovan, George Valeriu
    Hadadi, Laszlo
    Hutanu, Adina
    Banescu, Claudia
    Dobreanu, Minodora
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [35] Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients
    El-Gebali, HH
    Tahir, SA
    Haider, SS
    El-Fakhri, MM
    SAUDI MEDICAL JOURNAL, 2000, 21 (02) : 184 - 189
  • [36] LDL size and risk of coronary heart disease in elderly men and women
    Mykkänen, L
    Kuusisto, J
    Haffner, SM
    Laakso, M
    Austin, MA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) : 2742 - 2748
  • [37] Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
    Laaksonen, Reijo
    Ekroos, Kim
    Sysi-Aho, Marko
    Hilvo, Mika
    Vihervaara, Terhi
    Kauhanen, Dimple
    Suoniemi, Matti
    Hurme, Reini
    Maerz, Winfried
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Vlachopoulou, Efthymia
    Lokki, Marja-Liisa
    Nieminen, Markku S.
    Klingenberg, Roland
    Matter, Christian M.
    Hornemann, Thorsten
    Juni, Peter
    Rodondi, Nicolas
    Raber, Lorenz
    Windecker, Stephan
    Gencer, Baris
    Pedersen, Eva Ringdal
    Tell, Grethe S.
    Nygard, Ottar
    Mach, Francois
    Sinisalo, Juha
    Luscher, Thomas F.
    EUROPEAN HEART JOURNAL, 2016, 37 (25) : 1967 - 1976
  • [38] Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
    Sun X.
    Zhang M.
    Sanagawa A.
    Mori C.
    Ito S.
    Iwaki S.
    Satoh H.
    Fujii S.
    Thrombosis Journal, 10 (1)
  • [39] Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease
    Dart, A
    Sherrard, B
    Simpson, H
    ATHEROSCLEROSIS, 1997, 130 (1-2) : 161 - 170
  • [40] Cholesterol, coronary heart disease, and stroke in the Asia Pacific region
    Zhang, X
    Patel, A
    Horibe, H
    Wu, Z
    Barzi, F
    Rodgers, A
    MacMahon, S
    Woodward, M
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2003, 32 (04) : 563 - 572
12345